CAM
Cormorant Asset Management’s Janux Therapeutics JANX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.7M | Sell |
1,500,000
-500,000
| -25% | -$11.6M | 2.58% | 10 |
|
|
2025
Q1 | $54M | Sell |
2,000,000
-100,000
| -5% | -$2.7M | 4.06% | 7 |
|
|
2024
Q4 | $112M | Buy |
2,100,000
+1,050,000
| +100% | +$56.2M | 6.17% | 3 |
|
|
2024
Q3 | $47.7M | Hold |
1,050,000
| – | – | 2.53% | 12 |
|
|
2024
Q2 | $44M | Buy |
1,050,000
+300,000
| +40% | +$12.6M | 2.54% | 14 |
|
|
2024
Q1 | $28.2M | Buy |
+750,000
| New | +$28.2M | 1.24% | 27 |
|